logo

Karen Kotloff, MD

Karen Kotloff, MD

Pediatric Infectious Disease Baltimore, MD

Professor of Pediatrics, University MD School of Medicine

Office Address

Office Map
  • 685 W. Baltimore St
    HSF 480
    Baltimore, MD 21201
    Phone: (410) 706-5328
    Fax: (410) 706-6205

Dr. Kotloff's Clinical Specialties & Interests

  • Pediatric Infectious Disease: General Pediatric Infectious Disease

Dr. Kotloff's Education & Medical Training

  • University of MarylandUniversity of MarylandFellowship, Infectious Disease
  • University of Pittsburgh Medical CenterUniversity of Pittsburgh Medical CenterResidency, Pediatrics
  • Temple Univ Sch of MedTemple University School of MedicineMedical School

Dr. Kotloff's Certifications & Licensure

  • MD State Medical LicenseMD State Medical License1983 - 2014
  • American Board of PediatricsAmerican Board of PediatricsPediatrics, 1985, Current
  • American Board of PediatricsAmerican Board of PediatricsPediatric Infectious Diseases, 1994, Current

Dr. Kotloff's Awards, Honors, & Recognition

  • SuperDoctors.comSuper DoctorSuperDoctors.com
  • American Academy of PediatricsFellow (FAAP)American Academy of Pediatrics

Dr. Kotloff's Clinical Trials

Dr. Kotloff's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Vaccine And Treatment Evaluation Units
    Vaccine And Treatment Evaluation UnitsNational Institute Of Allergy And Infectious Diseases
    2010 - 2010
  • Vaccine And Treatment Evaluation Units
    Vaccine And Treatment Evaluation UnitsNational Institute Of Allergy And Infectious Diseases
    2010 - 2010
  • Vaccine And Treatment Evaluation Units
    Vaccine And Treatment Evaluation UnitsNational Institute Of Allergy And Infectious Diseases
    2009 - 2009
  • UMB Clinical Core
    UMB Clinical CoreNational Institute Of Allergy And Infectious Diseases
    2008 - 2008
  • Clinical Trial: Phase 1 Study Of The Safety &Immunogenicity Of Shigella/Etec VA
    Clinical Trial: Phase 1 Study Of The Safety &Immunogenicity Of Shigella/Etec VANational Center For Research Resources
    2008 - 2008
  • Shigella CVD 25000g: Phase 1, Randomized, Double-Blind, Placebo-Controlled, D
    Shigella CVD 25000g: Phase 1, Randomized, Double-Blind, Placebo-Controlled, DNational Center For Research Resources
    2007 - 2007
  • Phase I Trial Of Live Oral Attenuated Shigella Flexneri 2A Vaccine CVD 1208s
    Phase I Trial Of Live Oral Attenuated Shigella Flexneri 2A Vaccine CVD 1208sNational Center For Research Resources
    2005 - 2005
  • Phase 1 Trial Of Live/Oral/Attenuated Shigella Flexneri
    Phase 1 Trial Of Live/Oral/Attenuated Shigella FlexneriNational Center For Research Resources
    2004 - 2004
  • GI Dysfunction In Children Born To Hiv-Infected Women
    GI Dysfunction In Children Born To Hiv-Infected WomenEunice Kennedy Shriver National Institute Of Child Health &Human Development
    1989 - 1993
  • Prevalence Of HIV-1 Infection In College Students
    Prevalence Of HIV-1 Infection In College StudentsNational Institute Of Allergy And Infectious Diseases
    1989 - 1992

Dr. Kotloff's Professional Memberships

  • FellowAmerican Academy of Pediatrics - AAPFellow

Hospital Affiliations


Physicians, view Dr. Kotloff's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV